Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABP-450 Phase 2 in Cervical Dystonia
NCT04849988Phase 2Completed
- Sponsor
- AEON Biopharma, Inc.
- Start
- Mar 2021
- Primary completion
- Jul 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in cervical dystonia (CD), sponsored by AEON Biopharma, Inc.. Started Mar 2021; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on NCT04849988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04849988.